CYIOS Corporation Announces it has Closed the Acquisition of Noir Medical Supplies
CYIOS Corp (OTC PINK:CYIO) has successfully closed the acquisition of Noir Medical Supplies, a company specializing in top-tier medical equipment and supplies. This strategic move is expected to drive significant revenue growth for CYIO. Noir's projected revenues for 2024 are set to exceed $7 million, up from $4.6 million in 2023, marking a substantial increase. The acquisition aims to create immediate and long-term shareholder value by leveraging CYIOS's expertise with Noir's diverse product offerings and distribution channels. The company anticipates continued year-over-year revenue growth and positive cash flow through 2025, positioning itself to capture new opportunities in the healthcare sector.
CYIOS Corp (OTC PINK:CYIO) ha completato con successo l'acquisizione di Noir Medical Supplies, un'azienda specializzata in attrezzature e forniture mediche di alta qualità. Questa mossa strategica è destinata a generare una significativa crescita dei ricavi per CYIO. I ricavi previsti di Noir per il 2024 supereranno i 7 milioni di dollari, rispetto ai 4,6 milioni di dollari del 2023, segnando un aumento sostanziale. L'acquisizione mira a creare valore immediato e a lungo termine per gli azionisti sfruttando l'expertise di CYIOS con le diverse offerte di prodotti e le reti di distribuzione di Noir. L'azienda prevede una continua crescita dei ricavi anno dopo anno e un flusso di cassa positivo fino al 2025, posizionandosi per catturare nuove opportunità nel settore sanitario.
CYIOS Corp (OTC PINK:CYIO) ha cerrado con éxito la adquisición de Noir Medical Supplies, una empresa especializada en equipos y suministros médicos de primera calidad. Este movimiento estratégico se espera que genere un crecimiento significativo en los ingresos de CYIO. Se proyecta que los ingresos de Noir para 2024 superen los 7 millones de dólares, frente a los 4,6 millones de dólares de 2023, marcando un aumento considerable. La adquisición tiene como objetivo crear valor inmediato y a largo plazo para los accionistas aprovechando la experiencia de CYIOS con la diversa oferta de productos y canales de distribución de Noir. La empresa anticipa un crecimiento continuo de los ingresos año tras año y un flujo de caja positivo hasta 2025, posicionándose para capturar nuevas oportunidades en el sector de la salud.
CYIOS Corp (OTC PINK:CYIO)가 노르 의료 용품의 인수를 성공적으로 마무리했습니다, 이는 최고급 의료 장비와 용품을 전문으로 하는 회사입니다. 이 전략적 결정은 CYIO의 수익 성장을 크게 촉진할 것으로 예상됩니다. 노르의 2024년 예상 수익은 700만 달러를 초과할 것으로 보이며, 이는 2023년의 460만 달러에서 증가한 것입니다. 이 인수는 CYIOS의 전문성을 활용하여 노르의 다양한 제품 제공 및 유통 채널과 함께 즉각적이고 장기적인 주주 가치를 창출하는 것을 목표로 하고 있습니다. 회사는 2025년까지 지속적인 연평균 수익 성장 및 긍정적인 현금 흐름을 예상하고 있으며, 의료 분야에서 새로운 기회를 포착할 준비를 하고 있습니다.
CYIOS Corp (OTC PINK:CYIO) a réussi à finaliser l'acquisition de Noir Medical Supplies, une entreprise spécialisée dans des équipements et fournitures médicales de haut niveau. Ce mouvement stratégique devrait entraîner une croissance significative des revenus pour CYIO. Les revenus projetés de Noir pour 2024 devraient dépasser 7 millions de dollars, contre 4,6 millions de dollars en 2023, ce qui représente une augmentation substantielle. L'acquisition vise à créer une valeur immédiate et à long terme pour les actionnaires en tirant parti de l'expertise de CYIOS avec la diversité des offres de produits et des canaux de distribution de Noir. L'entreprise prévoit une croissance continue des revenus d'une année sur l'autre et un flux de trésorerie positif jusqu'en 2025, se positionnant pour saisir de nouvelles opportunités dans le secteur de la santé.
CYIOS Corp (OTC PINK:CYIO) hat die Übernahme von Noir Medical Supplies erfolgreich abgeschlossen, einem Unternehmen, das sich auf hochwertige medizinische Geräte und Materialien spezialisiert hat. Dieser strategische Schritt wird voraussichtlich ein signifikantes Umsatzwachstum für CYIO fördern. Die prognostizierten Umsätze von Noir für 2024 werden voraussichtlich 7 Millionen Dollar übersteigen, gegenüber 4,6 Millionen Dollar im Jahr 2023, was eine erhebliche Steigerung darstellt. Die Übernahme soll einen sofortigen und langfristigen Mehrwert für die Aktionäre schaffen, indem die Expertise von CYIOS mit den vielfältigen Produktangeboten und Vertriebskanälen von Noir genutzt wird. Das Unternehmen rechnet bis 2025 mit einem fortwährenden jährlichen Umsatzwachstum und einem positiven Cashflow und positioniert sich, um neue Chancen im Gesundheitssektor zu nutzen.
- Acquisition of Noir Medical Supplies successfully closed
- Projected revenue growth from $4.6M in 2023 to over $7M in 2024
- Expectation of continued year-over-year revenue growth through 2025
- Anticipation of positive cash flow
- Expansion into the healthcare sector with diverse product offerings
- None.
Noir Expects to See Strong Revenue Growth in 2024 Exceeding
BOCA RATON, FL / ACCESSWIRE / September 11, 2024 / CYIOS Corp (OTC PINK:CYIO), a publicly traded holding company, is pleased to announce it has successfully closed the strategic acquisition of Noir Medical Supplies, ("Noir") a company specializing in providing top-tier medical equipment and supplies. The acquisition marks a significant milestone for CYIOS with anticipated strong revenue growth in 2024 exceeding
To hear more about this acquisition, we invite you to join company Chairman John O'Shea for a fireside chat today at 4:05pm ET, click here: https://x.com/cyioscorp
John O'Shea, Chairman CYIOS Corporation commented: "We are thrilled to announce the successful closing of Noir Medical Supplies, which we see as a pivotal move to drive revenue growth while creating immediate and long-term shareholder value. With the strong demand for high-quality healthcare products and medical supplies, coupled with our strategic expansion, we are confident in our ability to deliver strong year-over-year revenue growth. The combination of CYIOS's expertise and Noir's diverse product offerings and distribution channels positions us well to capture new opportunities in the healthcare sector. Noir's revenues for 2024 are on target to exceed
About Noir Medical Supplies
Noir Medical Supplies (https://noirmedicalsupplies.com/) is a rapidly growing provider of high-quality medical supplies and equipment. Established in 2023, Noir has quickly become a trusted name in the healthcare industry, offering a comprehensive range of products including personal protective equipment (PPE), diagnostic devices, and essential healthcare items for clinics, hospitals, and medical professionals. Noir's business model focuses on sourcing and supplying overstock, distressed, and direct purchase inventories to deliver high-quality products at competitive prices. Noir's clientele includes some of the largest healthcare and biotech companies in the United States. Additional information regarding clients served as well as distribution partners can be found on the company's website.
Noir's Mission is to solve inventory challenges for medical institutions and healthcare distributors, ensuring that they have access to the necessary products to operate efficiently and effectively. With a commitment to excellence and customer satisfaction, Noir aims to expand its reach and product offerings, addressing the diverse needs of the healthcare sector across the United States and the Caribbean. Since our inception, Noir has seen consistent revenue growth and is on track to meet its ambitious financial targets.
CYIOS CONTACT INFORMATION
Public and Investor Relations: admin@cyioscorporation.com
Investors are encouraged to follow CYIOS at: https://twitter.com/cyioscorp
About CYIOS Corporation
CYIOS Corporation (OTC PINK:CYIO) is a publicly traded company focused on strategic investments and acquisitions in high-growth sectors, including healthcare, medical technology, and emerging industries. CYIOS is committed to innovation and excellence, aiming to build a portfolio of companies that deliver long-term value to shareholders. For more information, please visit: CYIOScorporation.com
FORWARD-LOOKING STATEMENTS: This release contains "forward-looking statements." Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management's current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified using words such as "anticipate," "intend," "plan," "goal," "seek," "believe," "project," "estimate," "expect," "strategy," "future," "likely," "may," "should," "would," "could," "will" & other words of similar meaning in connection with a discussion of future operating or financial performance. Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company's actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered w/ these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.
SOURCE: CYIOS Corp.
View the original press release on accesswire.com
FAQ
What company did CYIOS Corp (CYIO) acquire?
How much revenue is Noir Medical Supplies expected to generate in 2024?
What is the strategic importance of CYIO's acquisition of Noir Medical Supplies?
Does CYIOS (CYIO) expect continued growth beyond 2024?
